These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2100344

  • 1. Preparation and preliminary evaluation of sustained-release acetylsalicylic acid tablets.
    Jovanović M, Jokić D, Durić Z, Tasić L, Jovicić G.
    Pharmazie; 1990 Nov; 45(11):869. PubMed ID: 2100344
    [No Abstract] [Full Text] [Related]

  • 2. [Preparations of acetylsalicylic acid sustained-release tablets on hydrophilic matrix forms].
    Süss W, Bruder K.
    Pharmazie; 1987 Jul; 42(7):457-8. PubMed ID: 3671471
    [Abstract] [Full Text] [Related]

  • 3. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ, Sawyer WT, Rittase RA, Maynard SA.
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Influence of ethanol on aspirin release from hypromellose matrices.
    Roberts M, Cespi M, Ford JL, Dyas AM, Downing J, Martini LG, Crowley PJ.
    Int J Pharm; 2007 Mar 06; 332(1-2):31-7. PubMed ID: 17084050
    [Abstract] [Full Text] [Related]

  • 8. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R, Kala H, Richter M, Babel W, Sattler K.
    Pharmazie; 1989 Aug 06; 44(8):545-7. PubMed ID: 2594825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J, Tavakoli N, Movahedian A.
    J Pharm Pharm Sci; 2004 Nov 15; 7(3):338-44. PubMed ID: 15576014
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sustained release isoniazid tablets. I--Formulation and in vitro evaluation.
    Bulut-Oner F, Capan Y, Kas S, Oner L, Hincal AA.
    Farmaco; 1989 Nov 15; 44(7-8):739-52. PubMed ID: 2590371
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA, Ghaly ES, Marti A.
    P R Health Sci J; 1993 Dec 15; 12(4):263-7. PubMed ID: 8140204
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R, Cerletti C, de Gaetano G, Dejana E, Galletti F, Urso R, Marzot M.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun 15; 24(6):313-8. PubMed ID: 3733281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.